A recent study found that Natural GLP-1 Agonists such as OzemPIC and Mounjaro are linked to a decrease in the risk of dementia and addiction, in exchange for increased risk of kidney, pancreas and digestive problems.
The study was conducted by researchers from the University of Washington in Saint -Louis, published in the “Nature Medicine” magazine, and was written by Yurrick Alert.
The demand for weight loss medications continues to rise, as a recent study reported that one in every 8 Americans took or currently used medications to treat diabetes, heart disease or obesity.
The media, patients, and even some doctors called GLP-1 the name “miracle medications” due to the deep weight loss among users. While these health benefits are well rooted, information is rare about the effects of medications on body organs systems.
Scientists at the University of Washington University in St. Louis and the health care system of the Ministry of Veterans Affairs in Saint -Lewis systematically evaluated health results between more than two million people with diabetes taking famous weight loss medications. They found wide connections to the benefits of cognitive and behavioral health, while they also revealed an increase in the risk of pancreatitis and kidney disease, among other things.
Popular popularity
The main author of the study, Dr. Ziyad Al -Ali, and the clinical epidemics and kidney disease that treats patients at the John J Kokran Hospital for the Old Warriors of the University of Washington Medicine in Saint -Louis: “Due to the modernity of medicines and their increasing popularity, it is important to systematically examine their effects on all body systems – While turning any stone- to understand what you do and what you do not do. “
He said: “The results of the study provide visions about some of the known and unrecognized interests and risks of these drugs, which may be beneficial to the clinical care and directing research agendas.”
The medications that are taken once a week simulates the naturally produced hormones that curb appetite and slow the digestion, which creates a feeling of satiety that lasts longer. Following a healthy diet and exercising also helps to lose weight.
In the study, researchers at the University of Washington University analyzed unknown medical records in a database kept by the US Old Warriors Affairs. They compared 175 healthy results among the old warriors who took the GLB-1 antithesis to treat diabetes and those who took more traditional medications.
In total, the data collection examined more than two million old warriors treated from diabetes from October 1, 2017 to December 31, 2023. Patients included people of different ages, ethnicities and gender.
Natural GLB -1 rejuvenators have been associated with great benefits on nervous and behavioral health, with lower risk of seizures and addiction to substances such as alcohol, hemp, stimulants, and opioids. People who took weight loss drugs also witnessed a decrease in the risks of suicide ideas, self -harm and pathological disorders, such as schizophrenia.
Reducing the risk of Alzheimer’s
The results of the University of Washington University also showed a decrease in the risk of cognitive nervous disorders such as Alzheimer’s and dementia.
Al-Ali said: “It is interesting that the Natural GLB -1 receptors are expressed in the brain areas participating in controlling impulses, rewards and addiction, which explains their effectiveness in reducing appetite disorders and addiction.”
He added: “These drugs also reduce brain inflammation and lead to weight loss; both workers may improve brain health and explain a low risk of diseases such as Alzheimer’s and dementia.”
The pancreas and kidneys
While the Nahedat GLB -1 drugs appear effectively against a wide range of health problems, the benefits associated with them are modest -about 10% to 20%, a decrease in most of the results.
Al -Ali said, “However, the humble effect does not negate the potential contrast .. Along with other interventions, such as lifestyle changes or other medications. “
The study also confirmed the results of previous research, which explain in detail the potential of medicines in reducing the risk of heart attacks, strokes, and other cardiovascular problems.
Al -Ali emphasized that his study also highlighted the possible negative aspects of medicines, including increasing the risk of digestive problems such as nausea, vomiting, diarrhea, and in rare cases of stomach paralysis. Al -Ali said: “These results were well documented in research … Our study has confirmed such results.”
But the new is the possible way that the GLP-1 anti-B-1 drugs can affect the pancreas and kidneys. While these negative effects are not common, they can be very dangerous; Doctors should be vigilant to signs of pancreatitis and monitor kidney function among people who take GLB -1.
Kidney problems can occur without symptoms until the condition reaches an advanced stage with limited treatment options.